Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Non‑pegylated Liposomal Doxorubicin for Patients With Recurrent Ovarian Cancer: A Multicentric Phase II Trial

Oncology Letters
Cancer ResearchOncology
2016English

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Shrinkage of Pegylated and Non-Pegylated Liposomes in Serum

Colloids and Surfaces B: Biointerfaces
SurfacesColloidInterfacesTheoretical ChemistryMedicineBiotechnologySurface ChemistryPhysical
2014English

Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin

Arquivos de Gastroenterologia
Gastroenterology
2016English

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2009English

Intensification With Pegylated Interferon During Treatment With Tenofovir in HIV-hepatitis B Virus Co-Infected Patients

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
2016English

Pegylated Interferon Alpha-Associated Optic Neuropathy

Journal of Neuro-Ophthalmology
MedicineOphthalmologyNeurology
2010English

Genetic Variation in STAT4 Is Associated With Treatment Response to Pegylated Interferon in Patients With Chronic Hepatitis B

Asian Pacific Journal of Allergy and Immunology
MedicineAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy